Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy

Sponsor: University of Campania Luigi Vanvitelli
Study ID: NCT01025934
Phase: PHASE4
Status: Completed

Conditions

Proliferative Diabetic Retinopathy

Eligibility Criteria

Sex: ALL
Age: N/A - N/A
Healthy Volunteers: Accepted

Interventions

Bevacizumab — DRUG
sham — OTHER

Study Details

The purpose of this study is to evaluate the role, the safety and the effectiveness of Intravitreal Bevacizumab injections as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy.

Key Dates

First listed: Dec 4, 2009
Status verified: Dec 2009

Study Design

Primary purpose: TREATMENT

Arms

Active Comparator: 7 days
Active Comparator: 20 days
Sham Comparator: sham